Introduction
Natdecita 50mg injection:

Natdecita 50mg injection contains the active substance decitabine. It is
an antineoplastic drug that belongs to the class of medications called DNA
methylation inhibitors. It is used to treat myelodysplastic syndrome (a group
of conditions in which the bone marrow produces blood cells that are misshapen
and do not produce enough healthy blood cells). It is also used to treat a type
of cancer called acute myeloid leukemia (AML). It works by stopping the cancer
cells from growing.

Do not take this injection if you are allergic to Natdecita 50mg
injection or any other ingredients of this medicine. Inform your physician if
you have an infection, decreased blood cell count, liver disease, kidney
disorder, and a heart disorder. This medicine is not recommended for children
or young people below 18 years of age. This medicine can cause a serious immune
reaction called differentiation syndrome. Report to your physician if you face
any symptoms of sudden difficulty in breathing, cough, fever, or swelling in
the body.

Natdecita 50mg injection should not be used in pregnant and
breastfeeding women. Inform your physician if you are pregnant or
breastfeeding. Use effective contraception throughout the therapy to avoid
pregnancy. The common adverse reactions are decreased white blood cells, red
blood cells, platelet counts, and increased body temperature.

Uses of Natdecita 50mg injection:

·
Myelodysplastic syndrome

·
Blood cancer

How
to consume Natdecita 50mg injection:

It will be given to you by a doctor or nurse in a hospital or clinic
setting trained in cancer chemotherapy. It is given as an intravenous infusion
drip (into your vein). This will take one hour. Do not self-administer the
injection. Your doctor will decide the dose and duration of the treatment based
on your disease severity, body weight, and other factors.